HIV/AIDS
Reports from University of California advance knowledge in HIV/AIDS
Published in Pain and Central Nervous System Week, November 24th, 2008
"Objectives A minority of HIV-infected patients taking an antiretroviral (ARV) regimen containing dideoxynucleosides (d-drugs) such as stavudine (d4T) and didanosine (DDI) experiences dose-limiting neuropathic pain and paraesthesias, usually within weeks of starting these drugs. Because d-drugs are among the few affordable options available in developing countries, continuing d-drug therapy would be a desirable strategy for many HIV-infected individuals," investigators in the United States report.
"Therefore, we evaluated the safety of continuing d-drug therapy. In a US cohort, we compared the rates of worsening neuropathic symptoms and signs in HIV-infected...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- BioMed Central
Computerized carer lessens dementia load - Children's Hospital Boston
Silencing growth inhibitors could help recovery from brain injury - Montreal Neurological Institute and Hospital
In the war against diseases, nerve cells need their armor - Salk Institute
Newborn neurons in the adult brain can settle in the wrong neighborhood - University of Melbourne
Australia leads world first global effort to improve diagnosis of genetic disorders - University of Pittsburgh Schools of the Health Sciences
Pittsburgh Compound B finds Alzheimer’s-associated plaques in symptom-free older adults - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
